[
  {
    "objectID": "index.html",
    "href": "index.html",
    "title": "Formulating data for meta-analyses",
    "section": "",
    "text": "This is the website for the second practical of the Training School – Impact of Meta-analyses on Clinical Practice."
  },
  {
    "objectID": "part_a.html",
    "href": "part_a.html",
    "title": "Part A",
    "section": "",
    "text": "Question 1\nWhich is the population under study in this review?\n\nHow is the disease/condition defined?\nWhat are the most important characteristics that describe these people?\nAre there any relevant demographic factors (e.g. age, sex, ethnicity)?\nAre there other types of people who should be excluded from the review?\n\n\n\nQuestion 2\nWhich are the interventions of the review?\n\n\nQuestion 3\nWhich are the comparisons of the review?\n\n\nQuestion 4\nWhich are the outcomes considered in this review?"
  },
  {
    "objectID": "part_a.html#formulate-the-review-question",
    "href": "part_a.html#formulate-the-review-question",
    "title": "Part A",
    "section": "",
    "text": "Question 1\nWhich is the population under study in this review?\n\nHow is the disease/condition defined?\nWhat are the most important characteristics that describe these people?\nAre there any relevant demographic factors (e.g. age, sex, ethnicity)?\nAre there other types of people who should be excluded from the review?\n\n\n\nQuestion 2\nWhich are the interventions of the review?\n\n\nQuestion 3\nWhich are the comparisons of the review?\n\n\nQuestion 4\nWhich are the outcomes considered in this review?"
  },
  {
    "objectID": "part_a.html#plan-eligibility-criteria",
    "href": "part_a.html#plan-eligibility-criteria",
    "title": "Part A",
    "section": "Plan eligibility criteria",
    "text": "Plan eligibility criteria\n\nQuestion 5\nWhich study designs are included?"
  },
  {
    "objectID": "part_a.html#search-for-potentially-relevant-studies",
    "href": "part_a.html#search-for-potentially-relevant-studies",
    "title": "Part A",
    "section": "Search for potentially relevant studies",
    "text": "Search for potentially relevant studies\n\nQuestion 6\nWhich study designs are included?"
  },
  {
    "objectID": "part_a.html#collect-data",
    "href": "part_a.html#collect-data",
    "title": "Part A",
    "section": "Collect data",
    "text": "Collect data\n\nQuestion 8\nWhere was the data extracted from?\n\nWhat were the databases considered?\nWere the results of ongoing trials included in literature search?\nLook at the search terms of Appendix 1 for the case of CENTRAL. Can you follow what is happening?\n\n\n\nQuestion 9\nCollection of data\n\nWhat are the key data reported regarding the included studies?\nWhat were the main reasons for exclusion of the considered studies?\nWhat were the results regarding ongoing trials?"
  },
  {
    "objectID": "part_a.html#select-eligible-studies",
    "href": "part_a.html#select-eligible-studies",
    "title": "Part A",
    "section": "Select eligible studies",
    "text": "Select eligible studies\n\nQuestion 7\nExtraction results:\n\nHow many studies were identified in total?\nHow many of those were ultimately considered for further analyses?\nWhat were the reasons for excluding the rest of the trials?"
  },
  {
    "objectID": "part_b.html",
    "href": "part_b.html",
    "title": "Part B",
    "section": "",
    "text": "Question 1\nImport the data and explain what they are about.\n\n\nQuestion 2\nHow many studies compare celecoxib to placebo with regard to pain in less than 24 weeks?\n\n\nQuestion 3\nIn total, how many patients received celecoxib and how many received placebo in the studies comparing these two treatments with regard to pain in less than 24 weeks?\n\n\nQuestion 4\nWhat was the average level of pain after 24 in less than 24 weeks in the celecoxib and the placebo patients?\n\n\nQuestion 5\nFor how many studies comparing celecoxib to placebo with regard to pain in less than 24 weeks do we not have information on the year they were conducted?\n\n\nQuestion 6\nWhat is the earliest, latest and median publication year of the studies comparing celecoxib to placebo with regard to all pain in less than 24 weeks, if we disregard any missing information?\n\n\nQuestion 7\nHow many studies compare celecoxib to placebo with regard to number of adverse events ?\n\n\nQuestion 8\nIn total, how many patients received celecoxib and how many received placebo in the studies comparing these two treatments with regard to number of adverse events?\n\n\nQuestion 9\nWhat was the average number of adverse events in the celecoxib and the placebo patients?"
  }
]